Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 29, 2026Endocrine Reviews

SSTR-Based Therapies for Gastroenteropancreatic and Thoracic Neuroendocrine Neoplasms

View Full Paper
Ask AI
Bookmark
Share

Authors

SGSimona Grozinsky-GlasbergBKBeata Kos-Kudla

Discussion

Loading...

Member takes

Overview

Concise review of SSTR-targeted therapies highlights unmet needs and emerging strategies in neuroendocrine neoplasms.

Key Points

  • This review aims to summarize the current state and future directions of SSTR-targeted therapies for neuroendocrine neoplasms.
  • Conducted a comprehensive literature review on SSTR and its role in neuroendocrine neoplasms.
  • Assessed the efficacy and limitations of current SSTR-targeted drugs and ligands.
  • Identified areas of insufficient knowledge and potential novel therapeutic approaches.
  • Outlined significant implications of SSTR in the diagnosis and treatment of neuroendocrine neoplasms.
  • Highlighted ongoing developments and research needs in the field of SSTR-targeted therapies.
  • Discussed limitations of the standard-of-care SSTR-targeted therapies and their efficacy.

Cite This Study

Grozinsky-Glasberg et al. (2026) studied this question.

synapsesocial.com/papers/69c8c2a4de0f0f753b39cfechttps://doi.org/10.1210/endrev/bnag007
View Full Paper
Ask AI
Bookmark
Share